Serum human epididymis protein 4 vs. carbohydrate antigen 125 and their combination for endometrial cancer diagnosis: a meta-analysis
- PMID: 27249595
Serum human epididymis protein 4 vs. carbohydrate antigen 125 and their combination for endometrial cancer diagnosis: a meta-analysis
Abstract
Objective: Cancer antigen 125 (CA125) and Human epididymis protein 4 (HE4) appear to be promising predictors for endometrial cancer (EC). However, conflicting results exist in the diagnostic performance comparison among CA125 and HE4.
Materials and methods: A systematic review was conducted using PubMed, EMBASE and other databases till December 2015. All studies included were closely assessed with the QUADAS. Diagnostic value of HE4, CA125 and HE4+CA125 was systematically evaluated, and comparison among the predictive performances of HE4, CA125 were conducted. Sensitivity, specificity, DOR (diagnostic odds ratio), and area under the SROC curve were summarized with a random model. Meta-regression was used to explore the heterogeneity.
Results: 8 studies including 1832 cases (1129 in the study group and 703 in the control group) were included in our meta-analysis. Mean estimates of HE4 and their 95% CIs were: sensitivity 0.53 (95% CI: 0.50-0.56), specificity 0.91 (95% CI: 0.89-0.93), DOR 17.01 (95% CI: 7.88-36.72). The area under the SROC curve of HE4 in the diagnosis of EC was 0.77. However, CA125 had lower sensitivity, specificity, DOR, and the area under the SROC in diagnosis of EC with sensitivity 0.26 (95% CI: 0.24-0.29), specificity 0.81 (95% CI: 0.78-0.84), DOR 2.61 (95% CI: 0.92-7.41), and the area under the SROC 0.37. In patients with EC diagnosed by HE4+CA125, the overall sensitivity was 0.58 (95% CI: 0.54-0.62) and a specificity of 0.92 (95% CI: 0.89-0.94) in predicting EC. DOR and the area under the SROC curve of HE4+CA125 for diagnosis of EC were 21.86 (95% CI: 11.08-43.15) and 0.83 respectively, which showed a higher level of diagnostic accuracy than HE4 alone.
Conclusions: HE4 is helpful for distinguishing EC from healthy and benign disease. CA125 is not better than HE4 either for EC diagnosis. HE4+CA125 is promising a predictor of EC to replace He4, but its utilization requires further exploration.
Similar articles
-
Serum Human Epididymis Protein 4 Combined with Carbohydrate Antigen 125 for Endometrial Carcinoma Diagnosis: A Meta-Analysis and Systematic Review.Genet Test Mol Biomarkers. 2019 Aug;23(8):580-588. doi: 10.1089/gtmb.2019.0046. Genet Test Mol Biomarkers. 2019. PMID: 31373853
-
Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.BMC Cancer. 2012 Jun 19;12:258. doi: 10.1186/1471-2407-12-258. BMC Cancer. 2012. PMID: 22712526 Free PMC article.
-
Comparison of serum human epididymis protein 4 and CA125 on endometrial cancer detection: A meta-analysis.Clin Chim Acta. 2019 Jan;488:215-220. doi: 10.1016/j.cca.2018.11.011. Epub 2018 Nov 7. Clin Chim Acta. 2019. PMID: 30414437
-
Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis.Sci Rep. 2021 Aug 27;11(1):17308. doi: 10.1038/s41598-021-96552-9. Sci Rep. 2021. PMID: 34453074 Free PMC article.
-
Human epididymis protein 4 in endometrial cancer: A meta-analysis.Clin Chim Acta. 2018 Jul;482:215-223. doi: 10.1016/j.cca.2018.03.040. Epub 2018 Apr 6. Clin Chim Acta. 2018. PMID: 29630870 Review.
Cited by
-
Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer.Front Oncol. 2020 Nov 3;10:559016. doi: 10.3389/fonc.2020.559016. eCollection 2020. Front Oncol. 2020. PMID: 33224875 Free PMC article. Review.
-
Bioinformatic screening for candidate biomarkers and their prognostic values in endometrial cancer.BMC Genet. 2020 Sep 22;21(1):113. doi: 10.1186/s12863-020-00898-4. BMC Genet. 2020. PMID: 32962636 Free PMC article.
-
Serum CA125 and HE4 as Biomarkers for the Detection of Endometrial Cancer and Associated High-Risk Features.Diagnostics (Basel). 2022 Nov 17;12(11):2834. doi: 10.3390/diagnostics12112834. Diagnostics (Basel). 2022. PMID: 36428894 Free PMC article.
-
The Role of Human Epididymis Protein 4 in the Diagnosis and Prognosis of Diseases: An Umbrella Review of Systematic Reviews and Meta-Analyses of Observational Studies.Front Med (Lausanne). 2022 Mar 24;9:842002. doi: 10.3389/fmed.2022.842002. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35402435 Free PMC article. Review.
-
Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspective.Ann Transl Med. 2017 Jul;5(13):276. doi: 10.21037/atm.2017.05.13. Ann Transl Med. 2017. PMID: 28758102 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous